Repetitive nerve stimulation transiently opens the mitochondrial permeability transition pore in motor nerve terminals of symptomatic mutant SOD1 mice

Neurobiology of Disease

Volumn 42, Issue 3, 2011, Pages 381-390

  Nguyen, Khanh T ^a   Barrett, John N ^a   García Chacón, Luis ^a   David, Gavriel ^a   Barrett, Ellen F ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Mitochondria; Mitochondrial calcium uptake; Mitochondrial membrane potential; Mitochondrial permeability transition pore; Motor nerve terminal; Motor neuron; Mouse models of familial amyotrophic lateral sclerosis; Oxidative stress; Superoxide dismutase 1 G85R; Superoxide dismutase 1 G93A

Indexed keywords

CALCIUM ION; COPPER ZINC SUPEROXIDE DISMUTASE; MITOCHONDRIAL PERMEABILITY TRANSITION PORE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; FAMILIAL DISEASE; MITOCHONDRION; MOUSE; MOUSE MUTANT; NERVE CELL MEMBRANE STEADY POTENTIAL; NERVE DEGENERATION; NERVE ENDING; NERVE STIMULATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; STIMULUS RESPONSE; WILD TYPE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; ELECTRIC STIMULATION; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; MICE, KNOCKOUT; MITOCHONDRIA; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; MOTOR NEURONS; MUSCLE, SKELETAL; PRESYNAPTIC TERMINALS; SUPEROXIDE DISMUTASE;

EID: 79954631234     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2011.01.031     Document Type: Article

References (73)

1. Angaut-Petit D., Molgo J., Connold A.L., Faille L. The levator auris longus muscle of the mouse: a convenient preparation for studies of short- and long-term presynaptic effects of drugs or toxins. Neurosci. Lett. 1987, 82:83-88.
2. Barber S.C., Shaw P.J. Oxidative stress in ALS: key role in motor neuron injury and therapeutic target. Free Radic. Biol. Med. 2010, 48:629-641.
3. Bernardi P., Vassanelli S., Veronese P., Colonna R., Szabo I., Zoratti M. Modulation of the mitochondrial permeability transition pore. Effect of protons and divalent cations. J. Biol. Chem. 1992, 267:2934-2939.
4. Bosco D.A., Morfini G., Karabacak N.M., Song Y., Gros-Louis F., Pasinelli P., et al. Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS. Nat. Neurosci. 2010, 13:1396-1403.
5. Brown M.R., Sullivan P.G., Geddes J.W. Synaptic mitochondria are more susceptible to Ca2+ overload than nonsynaptic mitochondria. J. Biol. Chem. 2006, 281:11658-11668.
6. Bruijn L.I., Becher M.W., Lee M.K., Anderson K.L., Jemkins N.A., Copeland N.G., et al. ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron 1997, 18:327-338.
7. Chalmers S., McCarron J.G. The mitochondrial membrane potential and Ca2+ oscillations in smooth muscle. J. Cell Sci. 2008, 121:75-85.
8. Chiu A.Y., Zhai P., Dal Canto M.C., Peters T.M., Kwon Y.W., Prattis S.M., et al. Age-dependent penetrance of disease in a transgenic mouse model of familial amyotrophic lateral sclerosis. Mol. Cell. Neurosci. 1995, 6:349-362.
9. Costantini P., Belzacq A.S., Vieira H.L.A., Larochette N., de Pablo M.A., Zamzami N., et al. Oxidation of a critical thiol residue of the adenine nucleotide translocator enforces Bcl-2-independent permeability transition pore opening and apoptosis. Oncogene 2000, 19:307-314.
10. Damiano M., Starkov A.A., Petri S., Kipiani K., Kiaei M., Mattiazzi M., et al. Neural mitochondrial Ca2+ capacity impairment precedes the onset of motor symptoms in G93A Cu/Zn-superoxide dismutase mutant mice. J. Neurochem. 2006, 96:1349-1361.
11. David G. Mitochondrial clearance of cytosolic Ca2+ in stimulated lizard motor nerve terminals proceeds without progressive elevation of mitochondrial matrix [Ca2+]. J. Neurosci. 1999, 19:7495-7506.
12. David G., Barrett E.F. Mitochondrial Ca2+ uptake prevents desynchronization of quantal release and minimizes depletion during repetitive stimulation of mouse motor nerve terminals. J. Physiol. Lond. 2003, 548:425-438.
13. David G., Modney B., Scappaticci K.A., Barrett J.N., Barrett E.F. Electrical and morphological factors influencing the depolarizing after-potential in rat and lizard myelinated axons. J. Physiol. 1995, 489:141-157.
14. David G., Barrett J.N., Barrett E.F. Evidence that mitochondria buffer physiological Ca2+ loads in lizard motor nerve terminals. J. Physiol. Lond. 1998, 509:59-65.
15. Erzen I., Cvetko E., Obreza S., Angaut-Petit D. Fiber types in the mouse levator auris longus muscle: a convenient preparation to study muscle and nerve plasticity. J. Neurosci. Res. 2000, 59:692-697.
16. Ezzi S.A., Urushitani M., Julien J.P. Wild-type superoxide dismutase acquires binding and toxic properties of ALS-linked mutant forms through oxidation. J. Neurochem. 2007, 102:170-178.
17. Fischer L.R., Culver D.G., Tennant P., Davis A.A., Wang M., Castellano-Sanchez A., et al. Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp. Neurol. 2004, 185:232-240.
18. Forsberg K., Jonsson P.A., Andersen P.M., Bergemalm D., Graffmo K.S., Hultdin M., Jacobsson J., Rosquist R., Marklund S.L., Brannstrom T. Novel antibodies reveal inclusions containing non-native SOD1 in sporadic ALS patients. PLoS ONE 2010, 5:el11552.
19. Forsythe I.D., Tsujimoto T., Barnes-Davies M., Cuttle M.F., Takahashi T. Inactivation of presynaptic calcium current contributes to synaptic depression at a fast central synapse. Neuron 1998, 20:797-807.
20. Frey D., Schneider C., Xu L., Borg J., Spooren W., Caroni P. Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases. J. Neurosci. 2000, 20:2534-2542.
21. Giorgi C., De Stefani D., Bononi A., Rizzuto R., Pinton P. Structural and functional link between the mitochondrial network and the endoplasmic reticulum. Int. J. Biochem. Cell Biol. 2009, 41:1817-1827.
22. Gunter T.E., Pfeiffer D.R. Mechanisms by which mitochondria transport calcium. Am. J. Physiol. 1990, 258:C755-C786.
23. Gurney M.E., Pu H., Chiu A.Y., Dal Canto M.C., Polchow C.Y., Alexander D.D., et al. Motor neuron degeneration in mice that express a human Cu/Zn superoxide dismutase mutation. Science 1994, 264:1772-1775.
24. Harraz M.M., Marden J.J., Zhou W., Zhang Y., Williams A., Sharov V.S. SOD1 mutations disrupt redox-sensitive Rac regulation of NADPH oxidase in a familial ALS model. J. Clin. Invest. 2008, 118:659-670.
25. Hegedus J., Putman C.T., Tyreman N., Gordon T. Preferential motor unit loss in the SOD1G93A transgenic mouse model of amyotrophic lateral sclerosis. J. Physiol. Lond. 2008, 586:3337-3351.
26. Hill B.G., Higdon A.N., Dranka B.P., Darley-Usmar V.M. Regulation of vascular smooth muscle cell bioenergetic function by protein glutathiolation. Biochim. Biophys. Acta 2010, 1797:285-295.
27. Hϋser J., Blatter L.A. Fluctuations in mitochondrial membrane potential caused by repetitive gating of the permeability transition pore. Biochem. J. 1999, 343:311-317.
28. Hϋser J., Rechenmacher C.E., Blatter L.A. Imaging the permeability pore transition in single mitochondria. Biophys. J. 1998, 74:2129-2137.
29. Ichas F., Mazat J.P. From calcium signaling to cell death: two conformations for the mitochondrial permeability transition pore. Switching from low- to high-conductance state. Biochim. Biophys. Acta 1998, 1366:33-50.
30. Israelson A., Arbel N., Da Cruz S., Ilieva H., Yamanaka K., Shoshan-Barmatz V., Cleveland D.W. Misfolded mutant SOD1 directly inhibits VDAC1 conductance in a mouse model of inherited ALS. Neuron 2010, 67:575-587.
31. Jha N., Jurma O., Lalli G., Liu Y., Pettus E.H., Greenamyre J.T., et al. Glutathione depletion in PC12 results in selective inhibition of mitochondrial complex I activity. Implications for Parkinson's disease. J. Biol. Chem. 2000, 275:26096-26101.
32. Jiang D., Zhao L., Clapham D.E. Genome-wide RNAi screen identifies Letm1 as a mitochondrial Ca2+/H+ antiporter. Science 2009, 326:144-147.
33. Johnson-Cadwell L.I., Jekabsons M.B., Wang A., Polster B.M., Nicholls D.G. 'Mild uncoupling' does not decrease mitochondrial superoxide levels in cultured cerebellar granule neurons but decreases spare respiratory capacity and increases toxicity to glutamate and oxidative stress. J. Neurochem. 2007, 101:1619-1631.
34. Kabashi E., Valdmanis P.N., Dion P., Rouleau G.A. Oxidized/misfolded superoxide dismutase-1: the cause of all amyotrophic lateral sclerosis?. Ann. Neurol. 2007, 62:553-559.
35. Karlsson J., Fong K.S., Hansson M.J., Elmer E., Csiszar K., Keep M.F. Life span extension and reduced neuronal death after weekly intraventricular cyclosporin injections in the G93A transgenic mouse model of amyotrophic lateral sclerosis. J. Neurosurg. 2004, 101:128-137.
36. Kawamata, H., Manfredi, G., 2010. Mitochondrial dysfunction and intracellular calcium dysregulation in ALS. Mech. Ageing Dev. 131, 517-526.
37. Kirichok Y., Krapivinsky G., Clapham D.E. The mitochondrial calcium uniporter is a highly selective ion channel. Nature 2004, 427:360-364.
38. Kirkinezos I.G., Hernandez D., Bradley W.G., Moraes C.T. An ALS mouse model with a permeable blood-brain barrier benefits from systemic cyclosporine A treatment. J. Neurochem. 2004, 88:821-826.
39. Kirkinezos I.G., Bacman S.R., Hernandez D., Oca-Cossio J., Arias L.J., Perez-Pinzon M.A., et al. Cytochrome c association with the inner mitochondrial membrane is impaired in the CNS of G93A-SOD1 mice. J. Neurosci. 2005, 25:164-172.
40. Kong J., Xu Z. Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1. J. Neurosci. 1998, 18:3241-3250.
41. Kushnareva Y.E., Sokolove P.M. Prooxidants open both the mitochondrial permeability transition pore and a low-conductance channel in the inner mitochondrial membrane. Arch. Biochem. Biophys. 2000, 376:377-388.
42. Li Q., Van de Velde C., Israelson A., Xie J., Bailey A.O., Dong M.-Q., Chun S.-J., Roy T., Winer L., Yates J.R., Capaldi R.A., Cleveland D.W., Miller T.M. ALS-linked mutant superoxide dismutase I (SOD1) alters mitochondrial protein composition and decreases protein import. Proc. Natl Acad. Sci. USA 2010, 107:21146-21151.
43. Liu J., Farmer J.D., Lane W.S., Friedman J., Weissman I., Schreiber S.L. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 1991, 66:807-815.
44. Marden J.J., Harraz M.M., Williams A.J., Nelson K., Luo M., Paulson H., et al. Redox modifier genes in amyotrophic lateral sclerosis in mice. J. Clin. Invest. 2007, 117:2913-2919.
45. Martin L.J. The mitochondrial permeability transition pore: a molecular target for amyotrophic lateral sclerosis therapy. Biochim. Biophys. Acta 2010, 1802:186-197.
46. Martin L.J., Gertz B., Pan Y., Price A.C., Molkentin J.D., Chang Q. The mitochondrial permeability transition pore in motor neurons: involvement in the pathobiology of ALS mice. Exp. Neurol. 2009, 218:333-346.
47. Mattiazzi M., D'Aurelio M., Gajewski C.D., Martushova K., Kiaei M., Beal M.F., et al. Mutated human SOD1 causes dysfunction of oxidative phosphorylation in mitochondria of transgenic mice. J. Biol. Chem. 2002, 277:29626-29633.
48. McStay G.P., Clarke S.J., Halestrap A.P. Role of critical thiol groups on the matrix surface of the adenine nucleotide translocase in the mechanism of the mitochondrial permeability transition pore. Biochem. J. 2002, 367:541-548.
49. Morita K., Barrett E.F. Evidence for two calcium-dependent potassium conductances in lizard motor nerve terminals. J. Neurosci. 1990, 10:2614-2625.
50. Murray L.M., Talbot K., Gillingwater T.H. Review: neuromuscular synaptic vulnerability in motor neurone disease: amyotrophic lateral sclerosis and spinal muscular atrophy. Neuropathol. Appl. Neurobiol. 2010, 36:133-156.
51. Naga K.K., Sullivan P.G., Geddes J.W. High cyclophilin D content of synaptic mitochondria results in increased vulnerability to permeability transition. J. Neurosci. 2007, 27:7469-7475.
52. Nguyen K.T., García-Chacón L.E., Barrett J.N., Barrett E.F., David G. The Ψm depolarization that accompanies mitochondrial Ca2+ uptake is greater in mutant SOD1 than in wild-type mouse motor terminals. Proc. Natl Acad. Sci. USA 2009, 106:2007-2011.
53. Nicholls D.G., Chalmers S. The integration of mitochondrial calcium transport and storage. J. Bioenerg. Biomembr. 2004, 36:277-281.
54. Nicholls D.G., Ferguson S.J. Bioenergetics 3 2002, Academic Press, London.
55. Nicholls D.G., Ward M.W. Mitochondrial membrane potential and neuronal glutamate excitotoxicity: mortality and millivolts. Trends Neurosci. 2000, 23:166-174.
56. Nizami S., Lee V.W.Y., Davies J., Long P., Jovanovic J.N., Sihra T.S. Presynaptic roles of intracellular Ca2+ stores in signalling and exocytosis. Biochem. Soc. Trans. 2010, 38:529-535.
57. Parone P.A., Da Cruz S., Garcia M.L., Forte M.A., Bernardi P., Cleveland D.W. Increasing mitochondrial calcium buffering capacity systemically in mice expressing ALS-linked mutations does not alter disease course. Program No. 656/13/N7. 2010 Neuroscience Meeting Planner 2010, Society for Neuroscience, San Diego, CA, Online.
58. Perocchi F., Gohil V.M., Girgis H.S., Bao X.R., McCombs J.E., Palmer A.E., Mootha V.K. MICU1 encodes a mitochondrial EF hand protein required for Ca2+ uptake. Nature 2010, 467:291-296.
59. Pun S., Santos A.F., Saxena S., Xu L., Caroni P. Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF. Nat. Neurosci. 2006, 9:408-419.
60. Rosen D.R., Siddique T., Patterson D.A., Figlewicz P., Sapp A., Hentati D., et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993, 362:59-62.
61. Saotome M., Katoh H., Yaguchi Y., Tanaka T., Urushida T., Satoh H., et al. Transient opening of mitochondrial permeability transition pore by reactive oxygen species protects myocardium from ischemia-reperfusion injury. Am. J. Physiol. Heart Circ. Physiol. 2009, 296:H1125-H1132.
62. Schaefer A.M., Sanes J.R., Lichtman J.W. A compensatory subpopulation of motor neurons in a mouse model of amyotrophic lateral sclerosis. J. Comp. Neurol. 2005, 490:209-219.
63. Shen D., Dalton T.P., Nebert D.W., Shertzer H.G. Glutathione redox state regulates mitochondrial reactive oxygen production. J. Biol. Chem. 2005, 280:25305-25312.
64. Shi P., Gal J., Kwinter D.M., Liu X., Zhu H. Mitochondrial dysfunction in amyotrophic lateral sclerosis. Biochim. Biophys. Acta 2010, 1802:45-51.
65. Spät A., Szanda G., Csordás G., Hajnóczky High and low calcium-dependent mechanisms of mitochondrial calcium signalling. Cell Calcium 2008, 44:51-63.
66. Tabti N., Bourret C., Mallart A. Three potassium currents in mouse motor nerve terminals. Pflugers Arch. 1989, 413:395-400.
67. Talbot J., Barrett J.N., Barrett E.F., David G. Stimulation-induced changes in NADH fluorescence and mitochondrial membrane potential in lizard motor nerve terminals. J. Physiol. 2007, 579:783-798.
68. Valentine J.S., Doucette P.A., Zittin Potter S. Copper-zinc superoxide dismutase and amyotrophic lateral sclerosis. Annu. Rev. Biochem. 2005, 74:563-593.
69. Vila L., Barrett E.F., Barrett J.N. Stimulation-induced mitochondrial [Ca2+] elevations in mouse motor terminals: comparison of wild-type with SOD1G93A. J. Physiol. Lond. 2003, 549:719-728.
70. Votyakova T.V., Reynolds I.J. Ca2+-induced permeabilization promotes free radical release from rat brain mitochondria with partially inhibited complex I. J. Neurochem. 2005, 93:526-537.
71. Woodfield K.A., Ruck A.D., Brdiczka D., Halestrap A.P. Direct demonstration of a specific interaction between cyclophilin-D and the adenine nucleotide translocase confirms their role in the mitochondrial permeability transition. Biochem. J. 1998, 336:287-290.
72. Wooley C.M., Sher R.B., Kale A., Frankel W.N., Cox G.A., Seburn K.L. Gait analysis detects early changes in transgenic SOD1(G93A) mice. Muscle Nerve 2005, 32:43-50.
73. Wu D.C., Ré D.B., Nagai M., Ischiropoulos H., Przedborski S. The inflammatory NADPH oxidase enzyme modulates motor neuron degeneration in amyotrophic lateral sclerosis mice. Proc. Natl Acad. Sci. USA 2006, 103:12132-12137.